Skip to content

Acupuncture in Postoperative Pain Control for Minimal Invasive Thoracoscopic Surgery Patients

Investigate the Efficacy of Acupuncture in Postoperative Pain Control for Minimal Invasive Thoracoscopic Surgery Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02959346
Enrollment
100
Registered
2016-11-09
Start date
2016-12-31
Completion date
2017-10-31
Last updated
2016-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Pain Control, Randomized Controlled Trial, Thoracic Surgery

Keywords

Minimal invasive thoracoscopic surgery, Pain control, Acupuncture, Randomized controlled trial

Brief summary

Minimal invasive thoracoscopic surgery has been used widely for common thoracic diseases in recent years. Patients who received thoracoscopic surgery recovered much quickly and returned to their daily life sooner because of small operation wound and less invasion. However, operative pain was still an important factor, which might contribute to several post-operative complications. In daily practice, patients received oral/intravenous form non-steroidal anti-inflammatory drugs and opioid agents, or patient-controlled analgesia for post operative pain control. However, some side effects were observed occasionally. The role of acupuncture in post-operative pain control was frequently discussed in recent research. The main mechanisms of acupuncture in pain control were (1) to stimulate the release of endogenous opioid and (2) to block TRPV1 receptor. The randomized controlled trial arranged by Gary Deng and his colleagues in 2008, was the first clinical trial investigated the role of acupuncture in post-operative pain control for traditional thoracotomy patients. However, there was no further research about the role of acupuncture applied to minimal invasive thoracoscopic surgery. Thus, the aim of this randomized controlled trial was to investigate the role of acupuncture in post-operative pain control for minimal invasive thoracoscopic surgery patients. In order to deliver a safe and effective way in pain control, and to save medical cost and promote quality of patient care.

Interventions

PROCEDURESham Acupuncture

Procedure: Sham Acupuncture(ipisilateral side, 0.3cun, No needle sensation (de qi) was elicited) Sham acupuncture will be applied by inserting acupuncture needle into acupoints(1cm away from the true acupoint):upper limb: Waiguan TE5; lower limb: Zusanli ST36. All procedures were carried out to a depth of 0.5 cm with disposable needles measuring 0.16 mm in diameter (40-gauge) and 12.7 mm in length (Yu Kuang, Taipei, Taiwan). Acupuncture treatment will consist of one session per day and consecutive three days after thoracoscopic surgery.

PROCEDUREAcupuncture

Procedure: Acupuncture(ipisilateral side, the needling depth decided by whether patients feel De qi, neutral supplementation and draining) Acupuncture will be applied by inserting acupuncture needle into acupoints: Zhigou TE6, Shousanli LI10, Hegu LI4, Neiguan PC6, Houxi SI3; lower limb: Biguan ST31, Fushe SP13, Zulinqi GB41; axillary area(Remove Needles right away after De qi): Yuanye GB22, Jiquan HT1; local area(Remove Needles right away after De qi): ashi point close to the pain area. The other needles will be left for 20 minutes and then removed. All procedures were carried out with disposable needles measuring 0.25 mm in diameter (32-gauge) and 44 mm in length (Yu Kuang, Taipei, Taiwan). Acupuncture treatment will consist of one session per day and consecutive three days after thoracoscopic surgery.

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age more than 20-year-old * Both male and female patients * Nationality: Republic of China (R.O.C., Taiwan) * Who received thoracoscopic surgery for benign lung tumor/disease, metastatic lung tumor, primary lung cancer, mediastinal tumor

Exclusion criteria

* Abnormal function of coagulation * Platelet count less than 20 x 10\^3/mm\^3 * International normalized ratio (INR) more than 2.5 * Severe comorbidity, for example central vascular, cardiovascular disease, liver/renal failure * Who would not cooperate in access, or express appropriately

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline pain scale at post operative day 2, after interventionmeasure at post-operative day 1, 9AM, before intervention; and post-operative day 2, 5PM, after intervention1. Pain, as assessed by Numeric Rating Scale, NRS 2. Measure at post-operative day 1, 9AM, before intervention; and post-operative day 2, 5PM, after intervention 3. accompanied with rest, deep breath, cough and change posture by left and right decubitus

Secondary

MeasureTime frameDescription
Opioid dosageinjection times of morphine or ketorolac would be recorded during whole admission, an average of 7 days1. Routine pain control was given with oral form acetaminophen (500mg, at every 9AM, 1PM, 5PM and 9PM) 2. Additional Morphine was given for intolerable pain (0.05mg/kg, intramuscular injection) 3. Additional Ketorolac was given for intolerable pain after morphine used (15mg, intramuscular injection) 4. Avoid patient controlled analgesia (PCA) using
Von Frey hair Testmeasure at post-operative day 1, 9AM, before intervention; and post-operative day 2, 5PM, after intervention1. Pain, as assessed by von Frey hair Test at each wound sites 2. Measure at post-operative day 1, 9AM, before intervention; and post-operative day 2, 5PM, after intervention
Vital signsmeasure during whole admission, an average of 7 days1. Measure at every 9AM, 1PM, 5PM and 9PM 2. Including blood pressure, heart rate, breath rate, body temperature
Questionnairemeasure before discharge, an average at post operative day 51\. Including quality control of acupuncture, discomfort and satisfaction during whole admission, an average of 7 days

Countries

Taiwan

Contacts

Primary ContactTing Yu Lu, MD
seawindss@hotmail.com+886-975682784

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026